1-4 of 4
Steven Dubinett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer

Siwen Hu-Lieskovan, Aaron Lisberg, Jesse M. Zaretsky, Tristan R. Grogan, Hira Rizvi, Daniel K. Wells, James Carroll, Amy Cummings, John Madrigal, Benjamin Jones, Jacklin Gukasyan, I. Peter Shintaku, Dennis Slamon, Steven Dubinett, Jonathan W. Goldman, David Elashoff, Matthew D. Hellmann, Antoni Ribas, Edward B. Garon
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (16): 5061–5068.
https://doi.org/10.1158/1078-0432.CCR-18-4275
Published: 15 August 2019
View article titled, Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer
Open the PDF for Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B32: RADIANCE: An open-label, nonrandomized, prospective biomarker study to assess analytic concordance between noninvasive testing and tissue testing for EGFR T790M mutation detection in patients with non-small cell lung cancer

Hatim Husain, Martin Dietrich, Steven Dubinett, David E. Gerber, Jeffrey Gregg, Michelle Shiller, Howard West, Kim Thai, Alvin Milner, Nabil Chehab, Christina Baik
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (17_Supplement): B32.
https://doi.org/10.1158/1557-3265.AACRIASLC18-B32
Published: 01 September 2018
View article titled, Abstract B32: RADIANCE: An open-label, nonrandomized, prospective biomarker study to assess analytic concordance between noninvasive testing and tissue testing for EGFR T790M mutation detection in patients with non-small cell lung cancer
Journal Articles

Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors

Helen Su, Claudia Bodenstein, Rebecca A. Dumont, Yann Seimbille, Steven Dubinett, Michael E. Phelps, Harvey Herschman, Johannes Czernin, Wolfgang Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5659–5667.
https://doi.org/10.1158/1078-0432.CCR-06-0368
Published: 04 October 2006
View article titled, Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors
Open the PDF for Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors in another window
Journal Articles

Cyclooxygenase-2-Dependent Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-6 in Non–Small Cell Lung Cancer

Harnisha Dalwadi, Kostyantyn Krysan, Nathalie Heuze-Vourc'h, Mariam Dohadwala, David Elashoff, Sherven Sharma, Nicholas Cacalano, Alan Lichtenstein, Steven Dubinett
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7674–7682.
https://doi.org/10.1158/1078-0432.CCR-05-1205
Published: 08 November 2005
View article titled, Cyclooxygenase-2-Dependent Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-6 in Non–Small Cell Lung Cancer
Open the PDF for Cyclooxygenase-2-Dependent Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-6 in Non–Small Cell Lung Cancer in another window